Diferencia entre revisiones de «Central retinal artery occlusion»
(Major expansion: stroke equivalent emphasis, GCA workup, AHA statement reference, management) |
(Strip excess bold) |
||
| Línea 1: | Línea 1: | ||
==Background== | ==Background== | ||
*Acute interruption of blood flow to the retinal artery causing retinal ischemia | *Acute interruption of blood flow to the retinal artery causing retinal ischemia | ||
*A | *A stroke equivalent — 15-25% of patients will have an acute stroke or TIA within 1 week<ref name="lee">Lee J, et al. Risk of stroke in patients hospitalized with central retinal artery occlusion. ''Stroke''. 2013;44(4):967-971. PMID 23399955.</ref> | ||
*'''Ophthalmologic emergency''' — retinal tolerance for ischemia is approximately 90-100 minutes | *'''Ophthalmologic emergency''' — retinal tolerance for ischemia is approximately 90-100 minutes | ||
*Permanent vision loss occurs in most patients despite treatment | *Permanent vision loss occurs in most patients despite treatment | ||
| Línea 16: | Línea 16: | ||
==Clinical Features== | ==Clinical Features== | ||
* | *Sudden, painless, monocular vision loss — often described as "lights went out" | ||
*Typically develops over seconds | *Typically develops over seconds | ||
*Severe visual acuity loss (often counting fingers or light perception only) | *Severe visual acuity loss (often counting fingers or light perception only) | ||
* | *Relative afferent pupillary defect (APD / Marcus Gunn pupil) | ||
*Fundoscopy: | *Fundoscopy: | ||
** | **Pale/white retina with cherry-red spot at fovea (pathognomonic) | ||
**Box-car segmentation of retinal vessels (intermittent blood flow) | **Box-car segmentation of retinal vessels (intermittent blood flow) | ||
**Retinal edema | **Retinal edema | ||
| Línea 37: | Línea 37: | ||
*'''ESR and CRP''' — '''stat''' to evaluate for giant cell arteritis (ESR >50 in GCA) | *'''ESR and CRP''' — '''stat''' to evaluate for giant cell arteritis (ESR >50 in GCA) | ||
**If GCA suspected: start treatment immediately (see below) | **If GCA suspected: start treatment immediately (see below) | ||
* | *Fundoscopic exam — cherry-red spot diagnostic | ||
* | *Intraocular pressure (IOP) — rule out [[Acute angle-closure glaucoma|acute glaucoma]] | ||
* | *CT/CTA head and neck — evaluate for stroke, carotid stenosis | ||
**May also obtain CTA to look for embolic source | **May also obtain CTA to look for embolic source | ||
* | *ECG — evaluate for atrial fibrillation | ||
* | *Echocardiogram — evaluate for cardiac embolic source | ||
*Labs: CBC, BMP, coagulation studies, lipid panel, HbA1c | *Labs: CBC, BMP, coagulation studies, lipid panel, HbA1c | ||
* | *MRI with DWI — assess for concurrent acute stroke | ||
==Management== | ==Management== | ||
*'''No proven treatment''' reliably restores vision; most interventions have limited evidence<ref name="mac">Mac Grory B, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. ''Stroke''. 2021;52(6):e282-e294. PMID 33843236.</ref> | *'''No proven treatment''' reliably restores vision; most interventions have limited evidence<ref name="mac">Mac Grory B, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. ''Stroke''. 2021;52(6):e282-e294. PMID 33843236.</ref> | ||
*Traditional temporizing measures (limited evidence): | *Traditional temporizing measures (limited evidence): | ||
** | **Ocular massage — intermittent digital pressure over closed eyelid (10-15 seconds on, 5 seconds off) | ||
**Attempt to dislodge embolus distally | **Attempt to dislodge embolus distally | ||
*Emergent ophthalmology consultation | *Emergent ophthalmology consultation | ||
* | *If GCA suspected (age >50, elevated ESR, headache, jaw claudication): | ||
** | **Methylprednisolone 1 g IV daily x 3 days or Prednisone 1 mg/kg PO | ||
**Do NOT wait for temporal artery biopsy to start treatment | **Do NOT wait for temporal artery biopsy to start treatment | ||
*Stroke workup: same as [[TIA]] / [[Stroke (main)|stroke]] | *Stroke workup: same as [[TIA]] / [[Stroke (main)|stroke]] | ||
| Línea 60: | Línea 60: | ||
==Disposition== | ==Disposition== | ||
* | *Admit for stroke workup (telemetry, vascular imaging, echocardiography) | ||
*Emergent ophthalmology consultation | *Emergent ophthalmology consultation | ||
*If GCA suspected: admit for IV steroids and temporal artery biopsy within 1-2 weeks | *If GCA suspected: admit for IV steroids and temporal artery biopsy within 1-2 weeks | ||
*Treat as | *Treat as stroke equivalent with aggressive risk factor modification | ||
==See Also== | ==See Also== | ||
Revisión actual - 09:26 22 mar 2026
Background
- Acute interruption of blood flow to the retinal artery causing retinal ischemia
- A stroke equivalent — 15-25% of patients will have an acute stroke or TIA within 1 week[1]
- Ophthalmologic emergency — retinal tolerance for ischemia is approximately 90-100 minutes
- Permanent vision loss occurs in most patients despite treatment
- Average age: 60-65 years
- Most common cause: thromboembolism from carotid artery atherosclerosis or cardiac source
Etiology
- Carotid artery atherosclerosis (most common)
- Cardiac embolism (atrial fibrillation, valvular disease, endocarditis)
- Giant cell arteritis (GCA) — must be excluded in patients >50
- Hypercoagulable states
- Vasculitis
- Dissection of carotid or ophthalmic artery
Clinical Features
- Sudden, painless, monocular vision loss — often described as "lights went out"
- Typically develops over seconds
- Severe visual acuity loss (often counting fingers or light perception only)
- Relative afferent pupillary defect (APD / Marcus Gunn pupil)
- Fundoscopy:
- Pale/white retina with cherry-red spot at fovea (pathognomonic)
- Box-car segmentation of retinal vessels (intermittent blood flow)
- Retinal edema
- Branch RAO: visual field defect corresponding to affected branch
Differential Diagnosis
- Central retinal vein occlusion (hemorrhages on fundoscopy, less acute)
- Retinal detachment
- Optic neuritis (painful with eye movement)
- Vitreous hemorrhage
- Giant cell arteritis (GCA) with anterior ischemic optic neuropathy
- Stroke affecting visual cortex
Evaluation
- ESR and CRP — stat to evaluate for giant cell arteritis (ESR >50 in GCA)
- If GCA suspected: start treatment immediately (see below)
- Fundoscopic exam — cherry-red spot diagnostic
- Intraocular pressure (IOP) — rule out acute glaucoma
- CT/CTA head and neck — evaluate for stroke, carotid stenosis
- May also obtain CTA to look for embolic source
- ECG — evaluate for atrial fibrillation
- Echocardiogram — evaluate for cardiac embolic source
- Labs: CBC, BMP, coagulation studies, lipid panel, HbA1c
- MRI with DWI — assess for concurrent acute stroke
Management
- No proven treatment reliably restores vision; most interventions have limited evidence[2]
- Traditional temporizing measures (limited evidence):
- Ocular massage — intermittent digital pressure over closed eyelid (10-15 seconds on, 5 seconds off)
- Attempt to dislodge embolus distally
- Emergent ophthalmology consultation
- If GCA suspected (age >50, elevated ESR, headache, jaw claudication):
- Methylprednisolone 1 g IV daily x 3 days or Prednisone 1 mg/kg PO
- Do NOT wait for temporal artery biopsy to start treatment
- Stroke workup: same as TIA / stroke
- Dual antiplatelet therapy, statin, carotid imaging
- Consider emergent catheter-directed intra-arterial thrombolysis (tPA) at specialized centers if <6 hours (experimental)
Disposition
- Admit for stroke workup (telemetry, vascular imaging, echocardiography)
- Emergent ophthalmology consultation
- If GCA suspected: admit for IV steroids and temporal artery biopsy within 1-2 weeks
- Treat as stroke equivalent with aggressive risk factor modification
See Also
- Central retinal vein occlusion
- Retinal detachment
- Stroke (main)
- Giant cell arteritis
- Acute angle-closure glaucoma
References
- ↑ Lee J, et al. Risk of stroke in patients hospitalized with central retinal artery occlusion. Stroke. 2013;44(4):967-971. PMID 23399955.
- ↑ Mac Grory B, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. Stroke. 2021;52(6):e282-e294. PMID 33843236.
